CD8A and type 1 diabetes mellitus: Interestingly, the loss-of-function mutation of the P2X7R prevents the development of T1DM, indicating that the extracellular ATP/P2X7R signaling might play a role in T1DM initiation by supplying energy to CD8+ T-cells and may serve as a potential target for T1DM treatment.